CD8⁺ CD28^- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.

ABSTRACT:

SUBMITTER: Kriegsmann K 

PROVIDER: S-EPMC11216978 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature